Compare like doses, and note the titration
Hair loss: the delayed side effect Hair loss related to GLP-1 therapy typically does not appear until months three to six, making it a delayed side effect that catches many users off guard
Insulin-based glycaemic control is the pharmacological cornerstone in type 1 diabetes and delays the onset and progression of kidney disease
All other efficacy parameters were measured from randomization, so that effects of liraglutide treatment versus placebo and orlistat could be assessed
11,107 After both forms of GLP-1 have been exposed to DPP-IV, they are either rendered inactive or become an antagonist for the GLP-1R
For the majority, this side effect grows more tolerable as time passes, particularly when the dose is titrated up gradually as in clinical trials